We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Progressive Fading of Longitudinal Melanonychia due to a Nail Matrix Melanocytic Nevus in a Child

Antonella Tosti, MD; Robert Baran, MD; Rossella Morelli, MD; Pier Alessandro Fanti, MD; Andrea Peserico, MD
Arch Dermatol. 1994;130(8):1076-1077. doi:10.1001/archderm.1994.01690080146030.
Text Size: A A A
Published online


Nail matrix melanocytic nevi are considered rare and only a few histologically proven melanocytic nevi of the nail matrix have been reported in the literature.1-5 Most of these cases have occurred in children.1-3,5 Clinical evidence that nevoid nail area melanosis in children may spontaneously regress over the years has recently been reported.1 However, all these cases lacked pathologic study. We describe the progressive fading of longitudinal melanonychia due to a nail matrix melanocytic nevus in a child.

Figure 1.Longitudinal melanonychia of the third right finger in June 1990. Note evident fading of the band in January 1991.

Report of a Case.  A 1-year-old boy was first referred to our department in June 1990 because of a band of longitudinal melanonychia of the third right fingernail. His parents said that they had first noticed a gradually enlarging pigmented band 4 months before, when the child was 8


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.